Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofloxacin for reducing the need for prostate biopsy in men with elevated PSA
IRCT20260902070871N1Phase 3Recruiting
- Sponsor
- Islamic Azad University
- Start
- Sep 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of ciprofloxacin in prostatitis (2 arms), sponsored by Islamic Azad University. Primary endpoint: Need for a biopsy. Started Sep 2026; status: recruiting.
02
Drugs
ciprofloxacin
03
Conditions
prostatitis
Beyond the preview
Go deeper on IRCT20260902070871N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260902070871N1.